Latest Food and Drug Administration Stories
REDWOOD CITY, Calif., May 15, 2013 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced it has completed enrollment in the European clinical study for its MicroCutter XCHANGE(TM) 30, a cartridge-based cutting/stapling device with a 5-millimeter shaft diameter and cross-sectional area more than six times smaller than standard 12-millimeter surgical staplers used today. The trial is designed to evaluate the safety of the XCHANGE 30 in a variety of gastrointestinal surgical...
Quarterly Index Finds Foreign Objects Responsible for 28 Percent of USDA Recalls; Sports Equipment Recalls Rising INDIANAPOLIS, May 15, 2013 /PRNewswire/ -- According to the ExpertRECALL Index released today, nearly three out of four food recalls in the first quarter of this year were issued by companies facing two or more recalls during the 90-day period, a situation that is taxing the resources of food companies to successfully navigate the logistical challenges and regulatory...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Sacramento, CA (PRWEB) May 14, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients who have taken the medication Byetta. The maker of the drug has agreed with moving the growing number of injury claims to a special federal court in California*. DrugRisk was created to improve the safety of those...
MERION STATION, Pa., May 14, 2013 /PRNewswire/ -- The Law Offices of Marc S. Henzel announces that a class action lawsuit against Aveo Pharmaceuticals, Inc. ("Aveo" or the "Company") (Nasdaq: AVEO) and certain of its officers was filed in United States District Court, District of Massachusetts, on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Aveo between January 3, 2012 and May 1, 2013, both dates inclusive (the "Class...
The May 14th Issue of The Food Journal Will Provide an In-Depth Analysis of The Use of "All Natural" Claims on Food and Beverage Packaging. SANTA MONICA, Calif., May 14, 2013 /PRNewswire/ -- With an abundance of "All Natural" claims on foods and beverages but no defined standard, the next edition of The Food Journal will examine the impact of "All Natural" to manufacturers, government agencies, brand managers, retailers and consumers and if the future is dim for the statement....
TAIPEI, Taiwan, May 14, 2013 /PRNewswire/ -- TWi Pharmaceuticals, Inc. (Taiwan OTC: 4180) today announced that it has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration (U.S. FDA). Guanfacine Hydrochloride Extended-Release Tablet is a central alpha2A-adrenergic receptor agonist indicated for the treatment of Attention Deficit...
Teleconference and Webcast to be held on Tuesday, May 14, 2013 CRANBURY, N.J., May 14, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced financial results for the third quarter ended March 31, 2013. The Company also summarized end-of-Phase 2 discussions with the U.S. Food and...
RxISK says that answers to these 12 questions could save your life Toronto, Canada (PRWEB) May 13, 2013 The medical team behind RxISK.org, today published a checklist to help patients and their health care professionals assess the risks and benefits of prescription medications. RxISK is the first free, independent website where patients, doctors, and pharmacists can research prescription drugs and easily report a drug side effect. RxISK provides an individualized causality report for...
The firm is currently evaluating Byetta lawsuits for those who have suffered from allegedly serious Byetta side effects. (PRWEB) May 13, 2013 On May 9 a woman filed a lawsuit against drug makers Amylin Pharmaceuticals and Eli Lilly in federal court, alleging that the companies failed to adequately warn her about type 2 diabetes drug Byetta’s link to thyroid cancer, according to court documents for Childress v. Amylin Pharmaceuticals LLC, et al., No. 3:13-1114 (U.S. District Court for...
Stein Mitchell Muse & Cipollone LLP Announces Largest Generic Drug Whistleblower Settlement in History WASHINGTON, May 13, 2013 /PRNewswire-USNewswire/ -- Stein Mitchell Muse & Cipollone LLP announced today that Ranbaxy Laboratories Limited ("Ranbaxy"), India's largest generic drug manufacturer, has agreed to pay $500 million to the United States and individual States to resolve allegations by the law firm's client, Dinesh S. Thakur, that Ranbaxy falsified drug data and...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
